Pazufloxacin (INN) is a fluoroquinolone antibiotic. It is sold in Japan under the brand names Pasil and Pazucross.
List of articles in "Drug" category - Page 242
Lafutidine
Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action. It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses […]
Aviptadil
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction.
Etofamide
Etofamide (INN also known as eticlordifene) is an antiprotozoal drug used in the treatment of amoebiasis.Its effect against Giardia lamblia has been described as modest.
Azaprocin
Azaprocin is a drug which is an opioid analgesic with approximately 10x the potency of morphine and a fast onset and short duration of action. It was discovered in 1963 […]
Ramoplanin
Ramoplanin (INN) is a glycolipodepsipeptide antibiotic drug derived from strain ATCC 33076 of Actinoplanes.
Enzalutamide
Enzalutamide (marketed as Xtandi and formerly known as MDV3100) is an androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation […]
Satavaptan
Satavaptan (INN; codenamed SR121463 planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was […]
5-MeO-MPMI
5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(αN-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992 and subsequently investigated […]
4-HO-MPMI
4-HO-MPMI (also known as 4-Hydroxy-N-methyl-(αN-trimethylene)tryptamine or lucigenol) is a tryptamine derivative that is a psychedelic drug. It was developed by the team led by David Nichols from Purdue University in […]